Page last updated: 2024-11-08

diethylnitrosamine and Hypoxia

diethylnitrosamine has been researched along with Hypoxia in 2 studies

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.

Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Liu, K1
Chen, J1
Zhao, Y1
Boland, J1
Ting, KK1
Lockwood, G1
McKenzie, C1
Kench, J1
Vadas, MA1
Gamble, JR1
McCaughan, GW1
Corpechot, C1
Barbu, V1
Wendum, D1
Kinnman, N1
Rey, C1
Poupon, R1
Housset, C1
Rosmorduc, O1

Other Studies

2 other studies available for diethylnitrosamine and Hypoxia

ArticleYear
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Animals; Diethylnitrosamine; Humans; Hypoxia; Infant; Liver Neoplasms; Mice; MicroRNAs; Tumor Microe

2023
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:5

    Topics: Alkylating Agents; Animals; Cells, Cultured; Collagen Type I; Collagen Type IV; Diethylnitrosamine;

2002